Pharmaceutical Sector

USFDA Approves Lupin’s Novel Drug

The USFDALupin Pharmaceuticals has approved Lupin’s Abbreviated New Drug Application (ANDA)

Equity Churn Pushes Up Dabur Pharma

Dabur India LimitedIn early trade, Dabur Pharma was trading up 1.51% to Rs 77.50 after 50 lakh

Torrent Pharma Top Gainer at BSE

Torrent PharmaTorrent Pharma ascended 6.61% to Rs 257.95 and topped gainers in BSE’s ‘A’ group shares. The other gainers in the list were ABB, LIC Housing Finance, Reliance Energy and GMR Infrastructure.
Freshly, Torrent Pharma Ahmedabad based healthcare company had instigated Rimonabant, which is an anti-obesity molecule, for the first time in India under the trade name Rimoslim. The drug aims many cardio-metabolic risk factors that can lead to obesity, type 2 diabetes or dyslipidaemia.

Glenmark Pharmaceuticals Soars High As USFDA Okays New Drug

Glenmark PharmaceuticalsGlenmark Pharmaceuticals climbed up 1.05% to R

Pfizer Bounces On Strong Q2 Results

PfizerOn reporting a 618.19% increase in net profit in Q2 May 2007, Pfizer lifted 1.18% to Rs 820.10 in a

Ranbaxy now Makes $100 Million Annually

Africa hasRanbaxy been a hushed moneymaker for India’s major drug manufacturing company Ranbaxy making a

Pages